4930432K09Rik Inhibitors
Chemical class Prr27 Inhibitors encompasses a range of compounds that can indirectly influence the function or expression of the proline-rich protein 27 by targeting various signaling pathways and cellular processes. The compounds listed here are not specific to Prr27 but have been chosen based on their ability to interact with signaling pathways that proteins with proline-rich domains may be involved in. For instance, inhibitors of PI3K, such as LY294002 and Wortmannin, can disrupt downstream signaling events that may regulate the interactions and functions of proteins like Prr27.
Similarly, compounds that inhibit mTOR, MEK, JNK, and p38 MAP kinase, including Rapamycin, U0126, SP600125, SB203580, and PD98059, can potentially alter the cellular signaling landscape, thereby affecting the transcriptional regulation or post-translational modifications of Prr27. Inhibitors of tyrosine kinases and Akt, such as PP2, Dasatinib, and Triciribine, can also modify the signaling environment, which could indirectly influence Prr27's role within the cell. Moreover, compounds like GF109203X and Y-27632 target PKC and ROCK, respectively, which can lead to changes in cytoskeletal dynamics and potentially impact the function or localization of proline-rich proteins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of phosphoinositide 3-kinases (PI3K), LY294002 can impact signaling pathways that involve protein interactions with proline-rich domains, potentially altering Prr27 interactions and function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which can disrupt downstream signaling that may influence proteins with proline-rich sequences like Prr27. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An inhibitor of the mammalian target of rapamycin (mTOR), Rapamycin can modify signaling pathways that affect protein synthesis and turnover, which may in turn affect Prr27 levels or interactions in the cell. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of mitogen-activated protein kinase (MEK), which is part of the MAPK/ERK pathway. By altering this pathway, U0126 can influence transcription factors that might regulate Prr27 expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), SP600125 can alter transcription factor activity and potentially influence the expression or function of proteins like Prr27. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, which is involved in inflammatory responses and can affect the overall signaling environment that Prr27 operates within. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can prevent the activation of the ERK pathway, likely altering the cellular context in which Prr27 functions. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
A selective inhibitor of Src family tyrosine kinases, PP2 can disrupt signaling cascades that may be relevant for the modulation of proteins with proline-rich domains. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor that can influence various signaling pathways, possibly affecting the cellular processes in which Prr27 is involved. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
An inhibitor of Akt phosphorylation/activation, Triciribine can affect cell survival and growth pathways that may indirectly impact the function or stability of Prr27. | ||||||